Tanya Stoyanova, PhD, Associate Professor, at David Geffen School of Medicine at UCLA is a 2025 NETRF Research Grant Award recipient!
Diagnosing gastroenteropancreatic neuroendocrine tumors (GEP-NETs) can be difficult, often requiring invasive procedures. Dr. Stoyanova’s research is exploring a new, less invasive approach—using a blood biomarker called UCHL1 to detect these tumors early.
This study will also investigate whether blocking UCHL1 could help slow tumor growth, offering a potential new treatment strategy. By making both diagnosis and therapy easier and more effective, this research could be a game-changer for patients.
This important work is generously sponsored by Katherine’s Light Foundation, LLC
Click the link below to learn more: https://netrf.org/…/uchl1-as-a-minimally-invasive…/
